Recruiting Now in Woburn Ma
New Psoriasis Clinical Trials in Woburn Ma
Medically Reviewed By
Dr. Sarah Jensen, MD, Board-Certified Rheumatologist
Residents of Woburn Ma, MA struggling with Psoriasis may qualify for a new investigational treatment study being conducted by leading Woburn Ma facilities.
No Insurance Needed
Identify New Options
Am I Eligible?
Check if you qualify for the Up to $1,200 compensation.
Diagnosed with Psoriasis?
Aged 18-65?
Live near Woburn Ma?
100% Free • No Insurance Required
FDA Guidelines Monitored
HIPAA Compliant Data
256-bit SSL Enrollment
Local Medical Insight
Clinical research for Psoriasis in Woburn Ma is supported by major MA medical networks and research universities, ensuring state-of-the-art care and oversight for all participants in Woburn Ma.
Location
The research center is conveniently located in Woburn Ma. Validation parking is provided for all visits. (Specific address revealed upon qualification).
Qualification
- Age 18 - 65
- Diagnosed with Psoriasis
- Trying to find better management options
Available Trials in Woburn Ma
NCT05744466(Verify on ClinicalTrials.gov)
A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
RECRUITINGPsoriasis
NCT03125655(Verify on ClinicalTrials.gov)
Regulation of Inflammatory Genes in Psoriasis
RECRUITINGPsoriasis
NCT03997786(Verify on ClinicalTrials.gov)
A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis
RECRUITINGPsoriasis
Environmental Factors in Woburn Ma
Living in Woburn Ma presents unique lifestyle factors that can influence the management of Psoriasis. Local weather patterns and urban stressors are important considerations for ongoing clinical research.
Patient FAQ: Woburn Ma
Is travel compensation available?
Yes, many trials in the area provide stipends for travel expenses.
Do I need insurance?
No, all study-related care and medication are provided at no cost.
Can I keep my current doctor?
Absolutely. Study participation is a supplemental care option.